Abnormal modulation of cell protective systems in response to ischemic/reperfusion injury is important in the development of mouse sickle cell hepatopathy

Haematologica

Volumn 96, Issue 1, 2011, Pages 24-32

  Siciliano, Angela ^a   Malpeli, Giorgio ^b   Platt, Orah S ^c   Lebouef, Christophe ^d,e,f   Janin, Anne ^d,e,f   Scarpa, Aldo ^b   Olivieri, Oliviero ^a   Amato, Eliana ^b   Corrocher, Roberto ^a   Beuzard, Yves ^f   de Franceschi, Lucia ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d INSERM   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f SAINT LOUIS HOSPITAL   (France)

Author keywords

Endothelial nitric oxide synthase; Heat shock protein 27; Heat shock protein 70; Inducible nitric oxide synthase; NF B p65; Peroxiredoxin 6

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; BILIVERDIN REDUCTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; OXIDOREDUCTASE; PEROXIREDOXIN 6; PHOSPHODIESTERASE I; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV; ROLIPRAM; SPLEEN EXONUCLEASE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; LIVER CELL; LIVER DISEASE; LIVER DYSFUNCTION; LIVER INJURY; LIVER ISCHEMIA; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REPERFUSION INJURY; SICKLE CELL ANEMIA; SICKLE CELL HEPATOPATHY; UPREGULATION;

ANEMIA, SICKLE CELL; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CYTOPROTECTION; FEMALE; HEME OXYGENASE-1; HEPATOCYTES; HSP27 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, TRANSGENIC; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PEROXIREDOXINS; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 78650995345     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.028506     Document Type: Article

References (50)

1. Nagel RL, Platt OS. Pathophysiology of sickle cell disease. In: Steinberg MH, Forget BG, Higgs DR, ed. Disorders of Haemoglobin: Genetics, Pathophysiology, Clinical Management. Cambridge, UK: Cambridge University Press, 2001:p. 494-526.
2. Eaton WA, Hofrichter J. Sickle cell hemoglobin polymerization. Adv Protein Chem. 1990;40:63-279.
3. Solovey AA, Solovey AN, Harkness J, Hebbel RP. Modulation of endothelial cell activation in sickle cell disease: a pilot study. Blood. 2001;97(7):1937-41.
4. Hebbel RP. Adhesion of sickle red cells to endothelium: myths and future directions. Transfus Clin Biol. 2008;15(1-2):14-8.
5. Banerjee S, Owen C, Chopra S. Sickle cell hepatopathy. Hepatology. 2001;33(5):1021-8.
6. Traina F, Jorge SG, Yamanaka A, de Meirelles LR, Costa FF, Saad ST. Chronic liver abnormalities in sickle cell disease: a clinicopathological study in 70 living patients. Acta Haematol. 2007;118(3):129-35.
7. Charlotte F, Bachir D, Nenert M, Mavier P, Galacteros F, Dhumeaux D, et al. Vascular lesions of the liver in sickle cell disease. A clinicopathological study in 26 living patients. Arch Pathol Lab Med. 1995;119 (1):46-52.
8. Mills LR, Mwakyusa D, Milner PF. Histopathologic features of liver biopsy specimens in sickle cell disease. Arch Pathol Lab Med. 1988;112(3):290-4.
9. Bauer TW, Moore GW, Hutchins GM. The liver in sickle cell disease. A clinicopathologic study of 70 patients. Am J Med. 1980; 69(6):833-7.
10. Sheehy TW. Sickle cell hepatopathy. South Med J. 1977;70(5):533-8.
11. Berry PA, Cross TJ, Thein SL, Portmann BC, Wendon JA, Karani JB, et al. Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment. Clin Gastroenterol Hepatol. 2007;5(12):1469-76; quiz 369.
12. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol. 2003;18(8):891-902.
13. Bynum TE, Boitnott JK, Maddrey WC. Ischemic hepatitis. Dig Dis Sci. 1979;24(2): 129-35.
14. Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev. 2009;89(4):1269-339.
15. Menger MD, Richter S, Yamauchi J, Vollmar B. Role of microcirculation in hepatic ischemia/reperfusion injury. Hepatogastroenterology. 1999;46 (Suppl 2): 1452-7.
16. Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY, Frenette PS. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med. 2009;15(4):384-91.
17. Sabaa N, de Franceschi L, Bonnin P, Castier Y, Malpeli G, Debbabi H, et al. Endothelin receptor antagonism prevents hypoxiainduced mortality and morbidity in a mouse model of sickle-cell disease. J Clin Invest. 2008;118(5):1924-33.
18. Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, Vercellotti GM. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest. 2006;116(3): 808-16.
19. Belcher JD, Mahaseth H, Welch TE, Vilback AE, Sonbol KM, Kalambur VS, et al. Critical role of endothelial cell activation in hypoxia- induced vasoocclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol. 2005;288(6):H2715-25.
20. Belcher JD, Mahaseth H, Kalambur VS, Welch TE, Swanlund DJ, Ma L, et al. Microvascular blood flow in transgenic sickle mice: prevention of stasis with polynitroxylalbumin. Sickle Cell Meeting; 2004; 2004. p. 19.
21. Dasgupta T, Hebbel RP, Kaul DK. Protective effect of arginine on oxidative stress in transgenic sickle mouse models. Free Radic Biol Med. 2006;41(12):1771-80.
22. Huber N, Sakai N, Eismann T, Shin T, Kuboki S, Blanchard J, et al. Age-related decrease in proteasome expression contributes to defective nuclear factor-kappaB activation during hepatic ischemia/reperfusion. Hepatology. 2009;49(5):1718-28.
23. Kuboki S, Okaya T, Schuster R, Blanchard J, Denenberg A, Wong HR, et al. Hepatocyte NF-kappaB activation is hepatoprotective during ischemia-reperfusion injury and is augmented by ischemic hypothermia. Am J Physiol Gastrointest Liver Physiol. 2007;292(1):G201-7.
24. Shin T, Kuboki S, Lentsch AB. Roles of nuclear factor-kappaB in postischemic liver. Hepatol Res. 2008;38(5):429-40.
25. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 1995;376 (6536):167-70.
26. de Franceschi L, Baron A, Scarpa A, Adrie C, Janin A, Barbi S, et al. Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation. Blood. 2003;102(3):1087-96.
27. De Franceschi L, Platt OS, Malpeli G, Janin A, Scarpa A, Leboeuf C, et al. Protective effects of phosphodiesterase-4 (PDE-4) inhibition in the early phase of pulmonary arterial hypertension in transgenic sickle cell mice. FASEB J. 2008;22(6):1849-60.
28. de Franceschi L, Turrini F, Honczarenko M, Ayi K, Rivera A, Fleming MD, et al. In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemia. Haematologica. 2004;89(11):1287-98.
29. Vera T, Stec DE. Moderate hyperbilirubinemia improves renal hemodynamics in ANG II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol. 2010;299(4):R1044-9.
30. Desaulniers JAH, Sturgeon, R, Berman SS. Atomic absorption determination of trace metals in marine sediments and biological tissue using a stabilized temperature platform furnace. Atomic Spectroscopy. 1985;6(5):125-7.
31. Miller-Ihli NJ. Graphite furnace atomic absorption spectrometry for the analysis of biological materials. Spectrochimica Acta. 1989;44(12):1221-7.
32. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, et al. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest. 2005;115(5):1232-40.
33. Espina V, Wulfkuhle JD, Calvert VS, VanMeter A, Zhou W, Coukos G, et al. Laser-capture microdissection. Nat Protoc. 2006;1(2):586-603.
34. Caretti E, Devarajan K, Coudry R, Ross E, Clapper ML, Cooper HS, et al. Comparison of RNA amplification methods and chip platforms for microarray analysis of samples processed by laser capture microdissection. J Cell Biochem. 2008;103(2):556-63.
35. Chimenti C, Pieroni M, Russo A, Sale P, Russo MA, Maseri A, et al. Laser microdissection in clinical cardiovascular research. Chest. 2005;128(4):2876-81.
36. Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W, Haegeman G. Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol. 2002;64(5-6):963-70.
37. Chen JS, Hsu YM, Chen CC, Chen LL, Lee CC, Huang TS. Secreted heat shock protein 90alpha induces colorectal cancer cell invasion through CD91/LRP-1 and NF-kappaBmediated integrin alphaV expression. J Biol Chem. 2010;285(33):25458-66.
38. Marks-Konczalik J, Chu SC, Moss J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem. 1998;273(35):22201-8.
39. Eum HA, Park SW, Lee SM. Role of nitric oxide in the expression of hepatic vascular stress genes in response to sepsis. Nitric Oxide. 2007;17(3-4):126-33.
40. Florczyk UM, Jozkowicz A, Dulak J. Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance. Pharmacol Rep. 2008;60(1):38-48.
41. Pachori AS, Smith A, McDonald P, Zhang L, Dzau VJ, Melo LG. Heme-oxygenase-1- induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. J Mol Cell Cardiol. 2007;43(5):580-92.
42. Kobayashi T, Sugawara Y, Ohkubo T, Imamura H, Makuuchi M. Effects of amrinone on hepatic ischemia-reperfusion injury in rats. J Hepatol. 2002;37(1):31-8.
43. Takahashi T, Shimizu H, Morimatsu H, Maeshima K, Inoue K, Akagi R, et al. Heme oxygenase-1 is an essential cytoprotective component in oxidative tissue Injury induced by hemorrhagic shock. J Clin Biochem Nutr. 2009;44(1):28-40.
44. Pachori AS, Melo LG, Hart ML, Noiseux N, Zhang L, Morello F, et al. Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. Proc Natl Acad Sci USA. 2004;101(33):12282-7.
45. Harstad EB, Klaassen CD. iNOS-null mice are not resistant to cadmium chlorideinduced hepatotoxicity. Toxicology. 2002; 175(1-3):83-90.
46. Kan WH, Hsu JT, Schwacha MG, Choudhry MA, Raju R, Bland KI, et al. Selective inhibition of iNOS attenuates trauma-hemorrhage/resuscitation-induced hepatic injury. J Appl Physiol. 2008;105(4): 1076-82.
47. Wunder C, Scott JR, Lush CW, Brock RW, Bihari A, Harris K, et al. Heme oxygenase modulates hepatic leukocyte sequestration via changes in sinusoidal tone in systemic inflammation in mice. Microvasc Res. 2004;68(1):20-9.
48. Lin HI, Wang D, Leu FJ, Chen CF, Chen HI. Ischemia and reperfusion of liver induces eNOS and iNOS expression: effects of a NO donor and NOS inhibitor. Chin J Physiol. 2004;47(3):121-7.
49. Pasupuleti N, Gangadhariah M, Padmanabha S, Santhoshkumar P, Nagaraj RH. The role of the cysteine residue in the chaperone and anti-apoptotic functions of human Hsp27. J Cell Biochem. 2010;110(2): 408-19.
50. Ishikawa H, Jin MB, Ogata T, Taniguchi M, Suzuki T, Shimamura T, et al. Role of cyclic nucleotides in ischemia and reperfusion injury of canine livers. Transplantation. 2002;73(7):1041-8.